These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 24288331)

  • 1. Hepatitis C virus E2 envelope glycoprotein core structure.
    Kong L; Giang E; Nieusma T; Kadam RU; Cogburn KE; Hua Y; Dai X; Stanfield RL; Burton DR; Ward AB; Wilson IA; Law M
    Science; 2013 Nov; 342(6162):1090-4. PubMed ID: 24288331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2.
    Vasiliauskaite I; Owsianka A; England P; Khan AG; Cole S; Bankwitz D; Foung SKH; Pietschmann T; Marcotrigiano J; Rey FA; Patel AH; Krey T
    mBio; 2017 May; 8(3):. PubMed ID: 28512091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C Virus Structure: Defined by What It Is Not.
    Dearborn AD; Marcotrigiano J
    Cold Spring Harb Perspect Med; 2020 Jan; 10(1):. PubMed ID: 31501263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2.
    Khan AG; Whidby J; Miller MT; Scarborough H; Zatorski AV; Cygan A; Price AA; Yost SA; Bohannon CD; Jacob J; Grakoui A; Marcotrigiano J
    Nature; 2014 May; 509(7500):381-4. PubMed ID: 24553139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a hepatitis C virus vaccine: the structural basis of hepatitis C virus neutralization by AP33, a broadly neutralizing antibody.
    Potter JA; Owsianka AM; Jeffery N; Matthews DJ; Keck ZY; Lau P; Foung SK; Taylor GL; Patel AH
    J Virol; 2012 Dec; 86(23):12923-32. PubMed ID: 22993159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.
    McCaffrey K; Boo I; Owczarek CM; Hardy MP; Perugini MA; Fabri L; Scotney P; Poumbourios P; Drummer HE
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis.
    Gopal R; Jackson K; Tzarum N; Kong L; Ettenger A; Guest J; Pfaff JM; Barnes T; Honda A; Giang E; Davidson E; Wilson IA; Doranz BJ; Law M
    PLoS Pathog; 2017 Dec; 13(12):e1006735. PubMed ID: 29253863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escape of Hepatitis C Virus from Epitope I Neutralization Increases Sensitivity of Other Neutralization Epitopes.
    Gu J; Hardy J; Boo I; Vietheer P; McCaffrey K; Alhammad Y; Chopra A; Gaudieri S; Poumbourios P; Coulibaly F; Drummer HE
    J Virol; 2018 May; 92(9):. PubMed ID: 29467319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for penetration of the glycan shield of hepatitis C virus E2 glycoprotein by a broadly neutralizing human antibody.
    Li Y; Pierce BG; Wang Q; Keck ZY; Fuerst TR; Foung SK; Mariuzza RA
    J Biol Chem; 2015 Apr; 290(16):10117-25. PubMed ID: 25737449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV Glycoprotein Structure and Implications for B-Cell Vaccine Development.
    Ströh LJ; Krey T
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic analysis of a broadly neutralizing antibody AR3C epitopes on Hepatitis C virus E2 envelope glycoprotein and their cross-reactivity.
    Sun J; Brusic V
    BMC Med Genomics; 2015; 8 Suppl 4(Suppl 4):S6. PubMed ID: 26681161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
    Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design.
    Flyak AI; Ruiz S; Colbert MD; Luong T; Crowe JE; Bailey JR; Bjorkman PJ
    Cell Host Microbe; 2018 Nov; 24(5):703-716.e3. PubMed ID: 30439340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Based Design of Hepatitis C Virus Vaccines That Elicit Neutralizing Antibody Responses to a Conserved Epitope.
    Pierce BG; Boucher EN; Piepenbrink KH; Ejemel M; Rapp CA; Thomas WD; Sundberg EJ; Weng Z; Wang Y
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the hepatitis C virus E1E2 glycoprotein complex.
    Torrents de la Peña A; Sliepen K; Eshun-Wilson L; Newby ML; Allen JD; Zon I; Koekkoek S; Chumbe A; Crispin M; Schinkel J; Lander GC; Sanders RW; Ward AB
    Science; 2022 Oct; 378(6617):263-269. PubMed ID: 36264808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region.
    Alhammad Y; Gu J; Boo I; Harrison D; McCaffrey K; Vietheer PT; Edwards S; Quinn C; Coulibaly F; Poumbourios P; Drummer HE
    J Virol; 2015 Dec; 89(24):12245-61. PubMed ID: 26378182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of Hepatitis C Virus Envelope Glycoprotein E1 Antigenic Site 314-324 in Complex with Antibody IGH526.
    Kong L; Kadam RU; Giang E; Ruwona TB; Nieusma T; Culhane JC; Stanfield RL; Dawson PE; Wilson IA; Law M
    J Mol Biol; 2015 Aug; 427(16):2617-28. PubMed ID: 26135247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding.
    He L; Cheng Y; Kong L; Azadnia P; Giang E; Kim J; Wood MR; Wilson IA; Law M; Zhu J
    Sci Rep; 2015 Aug; 5():12501. PubMed ID: 26238798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Sequence and Functional Evolution within Glycoprotein E2 in Hepatitis C Virus Genotype 3a Infection.
    Alhammad YM; Maharajh S; Butcher R; Eden JS; White PA; Poumbourios P; Drummer HE
    PLoS One; 2015; 10(5):e0126397. PubMed ID: 25970466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants.
    Khera T; Behrendt P; Bankwitz D; Brown RJP; Todt D; Doepke M; Khan AG; Schulze K; Law J; Logan M; Hockman D; Wong JAJ; Dold L; Gonzalez-Motos V; Spengler U; Viejo-Borbolla A; Ströh LJ; Krey T; Tarr AW; Steinmann E; Manns MP; Klein F; Guzman CA; Marcotrigiano J; Houghton M; Pietschmann T
    J Hepatol; 2019 Apr; 70(4):593-602. PubMed ID: 30439392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.